On Tuesday, April 17, the journal Nature Scientific Reports published our paper “Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.” A few hours later, a reporter from BBC World Service reached out to discuss the the results of our study.
Live Interview
You can listen to this clip with my 4-minute interview on the BBC World Service program Newsday, broadcast across Europe and Africa during breakfast-time and the US airing on NPR around midnight.
Our mathematical model of HIV vaccine implementation in South Africa was developed by a team of researchers, and only possible with enormous contributions from Dr. Simon de Montigny at CHU Sainte-Justine Research Centre in Montreal and Dr. Dobromir Dimitrov at the Vaccine and Infectious Diseases Division at the Fred Hutchinson Cancer Research Center in Seattle.
“The value of an HIV vaccine depends not just how effective it is in a perfectly controlled randomized control trial, but the real-world value depends on the way governments decide to introduce and deliver it – whether through mass campaigns or routine clinic administration.”
Sources
de Montigny S, Adamson B, Masse B, Garrison L, Kublin J, Gilbert P, Dimitrov D. Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study. Nature Scientific Reports. 2018 Apr; 8(6066):1-12. DOI:10.1038/s41598-018-24268-4.
Interview clip from BBC World Service program Newsday 20:06 broadcast on 17 April 2018, posted for educational purposes in compliance with BBC copyright policy. Credit to Dr. Nina Miller for capturing the recording posted here.